Swedbank AB Boosts Position in Axon Enterprise, Inc $AXON

Swedbank AB boosted its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 1.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 110,683 shares of the biotechnology company’s stock after acquiring an additional 1,820 shares during the quarter. Swedbank AB owned 0.14% of Axon Enterprise worth $62,860,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Stone House Investment Management LLC purchased a new stake in Axon Enterprise during the third quarter valued at $29,000. New Millennium Group LLC purchased a new stake in Axon Enterprise during the third quarter valued at $29,000. Sound Income Strategies LLC increased its position in Axon Enterprise by 550.0% during the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after acquiring an additional 44 shares during the last quarter. Camelot Portfolios LLC purchased a new stake in Axon Enterprise during the fourth quarter valued at $30,000. Finally, Root Financial Partners LLC purchased a new stake in Axon Enterprise during the third quarter valued at $34,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently commented on AXON shares. Wall Street Zen upgraded Axon Enterprise from a “sell” rating to a “hold” rating in a research report on Saturday, February 28th. Royal Bank Of Canada reduced their price objective on Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating for the company in a research report on Wednesday, February 25th. The Goldman Sachs Group reduced their price target on Axon Enterprise from $720.00 to $625.00 and set a “buy” rating for the company in a research report on Wednesday, April 8th. Piper Sandler reduced their price target on Axon Enterprise from $753.00 to $690.00 and set an “overweight” rating for the company in a research report on Wednesday, February 25th. Finally, William Blair restated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 3rd. Sixteen equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $749.63.

Axon Enterprise Stock Performance

Shares of AXON opened at $385.86 on Thursday. The company has a quick ratio of 2.29, a current ratio of 2.53 and a debt-to-equity ratio of 0.53. The business has a 50-day simple moving average of $452.24 and a two-hundred day simple moving average of $529.24. The stock has a market cap of $31.09 billion, a price-to-earnings ratio of 253.86, a PEG ratio of 8.12 and a beta of 1.44. Axon Enterprise, Inc has a 52 week low of $339.01 and a 52 week high of $885.91.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 EPS for the quarter, topping analysts’ consensus estimates of $1.60 by $0.55. The business had revenue of $796.72 million during the quarter, compared to analysts’ expectations of $755.29 million. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The business’s quarterly revenue was up 38.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.08 earnings per share. On average, analysts expect that Axon Enterprise, Inc will post 1.41 EPS for the current year.

Axon Enterprise News Roundup

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Q1 revenue of ~$807M, up ~34% year‑over‑year; software & services grew ~35% and AI/counter‑drone products posted very large percentage gains — clear top‑line momentum that beat consensus. PR Newswire Release
• Positive Sentiment: Company raised its full‑year revenue growth outlook (to roughly 30–32% growth) and reiterated a strong Adjusted EBITDA margin target and free cash flow expectations — a constructive guidance update. Reuters: Raises Forecast
• Positive Sentiment: Non‑GAAP EPS of $1.61 was roughly in line with/just above some consensus models and revenue beat consensus by a solid margin — supports the narrative of profitable growth. Yahoo Finance: Q1 Results
• Neutral Sentiment: Analysts and previews had already priced in strong TASER, body‑camera and software demand; some brokerage notes suggested Axon could raise the low end of FY guidance even before the print (a pre‑earnings positioning effect). Yahoo Preview
• Neutral Sentiment: Company released supplemental materials (press release, slide deck and call transcript) — useful for digging into product KPIs and margin drivers but neutral until new customer/contract details emerge. MarketBeat: Materials
• Negative Sentiment: Some outlets and models flagged an EPS shortfall versus certain estimates (Zacks noted a miss vs its $1.66 consensus), creating confusion about the quality of the beat. Zacks: EPS vs Estimates
• Negative Sentiment: Despite the top‑line beat and raised guide, some trading sessions showed the stock slipping — investors remain concerned about high valuation, margin sustainability and a large YTD share price decline that reduces upside from good prints. Yahoo: Valuation/Performance
• Negative Sentiment: Intraday headlines noted shares “slip” in some sessions despite results, highlighting the mixed market reception and that execution vs. model expectations still matters to investor sentiment. Benzinga: Market Reaction

Insider Transactions at Axon Enterprise

In other news, Director Erika Nardini sold 198 shares of the company’s stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $506.58, for a total value of $100,302.84. Following the completion of the transaction, the director owned 1,946 shares of the company’s stock, valued at $985,804.68. This represents a 9.24% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Isaiah Fields sold 2,000 shares of the company’s stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $535.01, for a total value of $1,070,020.00. Following the completion of the transaction, the insider directly owned 55,588 shares of the company’s stock, valued at approximately $29,740,135.88. This trade represents a 3.47% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 13,855 shares of company stock valued at $7,109,828. 4.40% of the stock is owned by corporate insiders.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.